On 2026-09-10, HSBC raised its GILD price target to $175 from $155 (+12.9%).
HSBC 于 2026-09-10 将 GILD 目标价上调至 $175，此前为 $155，变动幅度 +12.9%。
For information only. Not investment advice.内容仅供参考，不构成投资建议。
GILD regulatory decision: FDA approves daily HIV pill from Gilead designed to simplify treatment for some patientsGilead Sciences, Inc.（GILD）的 产品 获美国 FDA 许可或批准
Material Company Event · August 27, 2026公司公告 · 2026/8/27
GILD earnings call: guidance, demand, margins, analyst Q&AGilead Sciences, Inc. (GILD) 电话会要点：指引、需求、利润率、分析师问答
Earnings Analysis · August 5, 2026财报电话会 · 2026/8/5
GILD earnings release — EPS beat · revenue beat +5.5%吉利德 (GILD) 财报发布 — EPS 高于预期 · 营收 高于预期+5.5%
Earnings Release · August 5, 2026财报快讯 · 2026/8/5
